A phase III randomized trial of cyclophosphamide, mitoxantrone, and 5-fluorouracil (CNF) versus cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) in patients with metastatic breast cancer

MLA

Miguel A. Seguí, et al. “A Phase III Randomized Trial of Cyclophosphamide, Mitoxantrone, and 5-Fluorouracil (CNF) versus Cyclophosphamide, Adriamycin, and 5-Fluorouracil (CAF) in Patients with Metastatic Breast Cancer.” Breast Cancer Research and Treatment, vol. 34, Apr. 1995, pp. 15–24. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....0b94d62e2e9b97e9cad90196425d63f2&authtype=sso&custid=ns315887.

APA

Miguel A. Seguí, Josep Tabernero, Sola C, M. C. Alonso, Marta Llanos, M. A. Climent, JJ López, & Belén Ojeda. (1995). A phase III randomized trial of cyclophosphamide, mitoxantrone, and 5-fluorouracil (CNF) versus cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) in patients with metastatic breast cancer. Breast Cancer Research and Treatment, 34, 15–24.

Chicago

Miguel A. Seguí, Josep Tabernero, Sola C, M. C. Alonso, Marta Llanos, M. A. Climent, JJ López, and Belén Ojeda. 1995. “A Phase III Randomized Trial of Cyclophosphamide, Mitoxantrone, and 5-Fluorouracil (CNF) versus Cyclophosphamide, Adriamycin, and 5-Fluorouracil (CAF) in Patients with Metastatic Breast Cancer.” Breast Cancer Research and Treatment 34 (April): 15–24. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....0b94d62e2e9b97e9cad90196425d63f2&authtype=sso&custid=ns315887.